
Levetiracetam API
| Name of Product | Levetiracetam API |
|---|---|
| CAS No | 102767‑28‑2 |
| Therapeutic use:- | Racetam anticonvulsant – used as monotherapy or adjunct for partial-onset, myoclonic, and generalized tonic‑clonic seizures |
| Grade | USP/EP/BP/IP/IH |
| Form:- | API Powder |
| Status | Commercial |
Product Overview
Levetiracetam is an active pharmaceutical ingredient (API) used in the management of epilepsy.
It is soluble in solvents like chloroform and ethanol, and is freely soluble in water.
The medication is stable when stored under the conditions specified.
It may degrade in the presence of high temperature, direct light, or humidity.
Levetiracetam is a pyrrolidone derivative.
It is different from the older antiepileptic drugs in that it has a novel mechanism of action.
It is not precisely understood how it works, though, but it is an SV2A synaptic vesicle protein binder.
This reduces the abnormal burst firing of neurons and controls seizures.
Therapeutic Applications
Levetiracetam is mainly used in the treatment of epilepsy.
It is effective for several seizure types, including partial-onset seizures, myoclonic seizures, and generalized tonic-clonic seizures.
Because of its unique action on the SV2A protein, Levetiracetam offers strong seizure control with a lower risk of drug interactions.
It does not act directly on sodium or calcium channels, unlike many older antiepileptic drugs.
Levetiracetam is valued for its broad safety profile.
It is usually given to patients who are not tolerant or responsive to other antiepileptics.
The API is also studied in neurological conditions linked to abnormal excitatory activity.
Specification Parameters
Packaging & Storage
Standard kinds of packaging are 25 kg fiber drums with inner double liners for maintaining humidity control.
Smaller packs from 1 to 5 kg are also available for pilot use and research projects.
Each pack is tamper-evident and carries the product name, batch number, net weight, and storage instructions.
The recommended storage is at 15–25 °C, dry, and away from strong light.
The material should be protected from high humidity and strong oxidizing agents.
Under these conditions, Levetiracetam remains stable for up to 36 months.
During handling, workers should use gloves, protective clothing, and eye protection.
Local exhaust systems are advised to reduce dust exposure.Â
Why Choose Us
Actiza Pharmaceutical Pvt. Ltd. supplies Levetiracetam with a focus on quality, compliance, and reliability.
Our product is manufactured in the highest quality cGMP facilities with validated processes.
Each lot is extensively tested before release.
We provide customers with a full COA, MSDS, impurity profile, and stability data.
Customization is possible. Customers can request micronized particle sizes, specialized packaging, or additional impurity controls.
Our technical team provides method transfer support and ensures USP, EP, and JP compliance.
Our supply chain is secure and dependable.
We have safety stocks, use qualified raw material suppliers, and ensure on-time delivery.
